Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Harry and Diane Rinker Health Science Campus, Chapman University School of Pharmacy, Irvine, CA 92618, USA.
Department of Pharmaceutical Chemistry, College of Pharmacy, Jazan University, Jazan 82826, Saudi Arabia.
Cells. 2022 Mar 29;11(7):1156. doi: 10.3390/cells11071156.
A series of cyclic peptides, [(DipR)(WR)], [(DipR)(WR)], [(DipR)(WR)], [(DipR)(WR)], and [DipR], and their linear counterparts containing arginine (R) as positively charged residues and tryptophan (W) or diphenylalanine (Dip) as hydrophobic residues, were synthesized and evaluated for their molecular transporter efficiency. The in vitro cytotoxicity of the synthesized peptides was determined in human epithelial ovary adenocarcinoma cells (SK-OV-3), human lymphoblast peripheral blood cells (CCRF-CEM), human embryonic epithelial kidney healthy cells (HEK-293), human epithelial mammary gland adenocarcinoma cells (MDA-MB-468), pig epithelial kidney normal cells (LLC-PK1), and human epithelial fibroblast uterine sarcoma cells (MES-SA). A concentration of 5-10 µM and 3 h incubation were selected in uptake studies. The cellular uptake of a fluorescent-labeled phosphopeptide, stavudine, lamivudine, emtricitabine, and siRNA was determined in the presence of peptides via flow cytometry. Among the peptides, [DipR] (10 µM) was found to be the most efficient transporter and significantly improved the uptake of F'-GpYEEI, i.e., by approximately 130-fold after 3 h incubation in CCRF-CEM cells. Confocal microscopy further confirmed the improved delivery of fluorescent-labeled [DipR] (F'-[K(DipR)]) alone and F'-GpYEEI in the presence of [DipR] in MDA-MB-231 cells. The uptake of fluorescent-labeled siRNA (F'-siRNA) in the presence of [DipR] with N/P ratios of 10 and 20 was found to be 30- and 50-fold higher, respectively, compared with the cells exposed to F'-siRNA alone. The presence of endocytosis inhibitors, i.e., nystatin, chlorpromazine, chloroquine, and methyl β-cyclodextrin, did not completely inhibit the cellular uptake of F'-[K(DipR)] alone or F'-GpYEEI in the presence of [DipR], suggesting that a combination of mechanisms contributes to uptake. Circular dichroism was utilized to determine the secondary structure, while transmission electron microscopy was used to evaluate the particle sizes and morphology of the peptides. The data suggest the remarkable membrane transporter property of [DipR] for improving the delivery of various small molecules and cell-impermeable negatively charged molecules (e.g., siRNA and phosphopeptide).
一系列的环状肽,[(DipR)(WR)],[(DipR)(WR)],[(DipR)(WR)],[(DipR)(WR)]和[DipR],以及它们的线性对应物,含有精氨酸(R)作为正电荷残基和色氨酸(W)或二苯丙氨酸(Dip)作为疏水性残基,被合成并评估了它们的分子转运效率。合成肽的体外细胞毒性在人上皮性卵巢腺癌细胞(SK-OV-3)、人淋巴母细胞外周血细胞(CCRF-CEM)、人胚胎上皮肾健康细胞(HEK-293)、人上皮性乳腺腺癌细胞(MDA-MB-468)、猪上皮性肾正常细胞(LLC-PK1)和人上皮性成纤维细胞子宫肉瘤细胞(MES-SA)中进行了测定。在摄取研究中选择了 5-10 µM 的浓度和 3 小时孵育。通过流式细胞术在肽存在的情况下测定了荧光标记的磷酸肽、司他夫定、拉米夫定、恩曲他滨和 siRNA 的细胞摄取。在这些肽中,[DipR](10 µM)被发现是最有效的转运体,并且在 CCRF-CEM 细胞中孵育 3 小时后,显著提高了 F'-GpYEEI 的摄取,即大约 130 倍。共聚焦显微镜进一步证实了在 MDA-MB-231 细胞中,单独的荧光标记的[DipR](F'-[K(DipR)])和 F'-GpYEEI 的递送得到了改善。在存在[DipR]的情况下,荧光标记的 siRNA(F'-siRNA)的摄取与单独暴露于 F'-siRNA 的细胞相比,分别提高了 30 倍和 50 倍。存在内吞抑制剂,即制霉菌素、氯丙嗪、氯喹和甲基-β-环糊精,并没有完全抑制单独的 F'-[K(DipR)]或 F'-GpYEEI 在[DipR]存在下的细胞摄取,这表明多种机制共同作用导致了摄取。圆二色性用于确定二级结构,而透射电子显微镜用于评估肽的粒径和形态。数据表明,[DipR]具有显著的膜转运特性,可提高各种小分子和细胞不可渗透的带负电荷分子(如 siRNA 和磷酸肽)的递药效率。